Search research articles
Contact Us
Filters
Showing results (21-30 of 23) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 23 results.
Plos Neglected Tropical Diseases
|
November 5, 2010
Geographical variation in the response of visceral leishmaniasis to paromomycin in East Africa: a multicentre, open-label, randomized trial
Asrat Hailu, Ahmed Musa, Monique Wasunna, et al.
Lancet (London, England)
|
March 16, 2020
Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trial
Richard O Phillips, Jérôme Robert, Kabiru Mohamed Abass, et al.
Plos Neglected Tropical Diseases
|
June 23, 2012
Sodium stibogluconate (SSG) & paromomycin combination compared to SSG for visceral leishmaniasis in East Africa: a randomised controlled trial
Ahmed Musa, Eltahir Khalil, Asrat Hailu, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 23) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 23 results.
Plos Neglected Tropical Diseases
|
November 5, 2010
Geographical variation in the response of visceral leishmaniasis to paromomycin in East Africa: a multicentre, open-label, randomized trial
Asrat Hailu, Ahmed Musa, Monique Wasunna, et al.
Lancet (London, England)
|
March 16, 2020
Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trial
Richard O Phillips, Jérôme Robert, Kabiru Mohamed Abass, et al.
Plos Neglected Tropical Diseases
|
June 23, 2012
Sodium stibogluconate (SSG) & paromomycin combination compared to SSG for visceral leishmaniasis in East Africa: a randomised controlled trial
Ahmed Musa, Eltahir Khalil, Asrat Hailu, et al.
Page
of 3